Fujifilm says its Avigan may be approved as Ebola drug by end-2014

TOKYO (Reuters) - Fujifilm Holdings Corp said it expects its influenza drug Avigan to be approved by international government bodies to treat Ebola as early as the end of the year.

Fujifilm has been growing its pharmaceutical division through a series of mergers and acquisitions as its photography business wanes. In 2008, it bought Toyama Chemical Co, whose drug Avigan has been drafted to the global fight against Ebola.